Enabling Technologies for Personalized and Precision MedicineDean Ho, Ali Zarrinpar, Stephen R. Quake et al.|Trends in biotechnology|2020Cited by 483
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working GroupPhilippe Moreau, Jean‐Luc Harousseau, Brian G.M. Durie et al.|The Lancet Oncology|2021Cited by 266
The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AMLJianbiao Zhou, Wee Joo Chng|Blood|2011Cited by 212
Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myelomaWee Joo Chng, P. Leif Bergsagel|Blood|2006Cited by 182
Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemiaJianbiao Zhou, Wee Joo Chng|Journal of Hematology & Oncology|2017Cited by 75